-
1
-
-
34547858847
-
High-density lipoprotein as a therapeutic target: A systematic review
-
I.M. Singh, M.H. Shishehbor, and B.J. Ansell High-density lipoprotein as a therapeutic target: a systematic review JAMA 298 2007 786 798
-
(2007)
JAMA
, vol.298
, pp. 786-798
-
-
Singh, I.M.1
Shishehbor, M.H.2
Ansell, B.J.3
-
3
-
-
77952357848
-
High-density lipoprotein heterogeneity and function in reverse cholesterol transport
-
G.H. Rothblat, and M.C. Phillips High-density lipoprotein heterogeneity and function in reverse cholesterol transport Curr. Opin. Lipidol. 21 2010 229 238
-
(2010)
Curr. Opin. Lipidol.
, vol.21
, pp. 229-238
-
-
Rothblat, G.H.1
Phillips, M.C.2
-
4
-
-
0034100119
-
The role of the high-density lipoprotein receptor SR-BI in cholesterol metabolism
-
B. Trigatti, A. Rigotti, and M. Krieger The role of the high-density lipoprotein receptor SR-BI in cholesterol metabolism Curr. Opin. Lipidol. 11 2000 123 131
-
(2000)
Curr. Opin. Lipidol.
, vol.11
, pp. 123-131
-
-
Trigatti, B.1
Rigotti, A.2
Krieger, M.3
-
5
-
-
0037413638
-
Ectopic beta-chain of ATP synthase is an apolipoprotein A-I receptor in hepatic HDL endocytosis
-
L.O. Martinez, S. Jacquet, J.P. Esteve, C. Rolland, E. Cabezon, E. Champagne, T. Pineau, V. Georgeaud, J.E. Walker, F. Terce, X. Collet, B. Perret, and R. Barbaras Ectopic beta-chain of ATP synthase is an apolipoprotein A-I receptor in hepatic HDL endocytosis Nature 421 2003 75 79
-
(2003)
Nature
, vol.421
, pp. 75-79
-
-
Martinez, L.O.1
Jacquet, S.2
Esteve, J.P.3
Rolland, C.4
Cabezon, E.5
Champagne, E.6
Pineau, T.7
Georgeaud, V.8
Walker, J.E.9
Terce, F.10
Collet, X.11
Perret, B.12
Barbaras, R.13
-
6
-
-
29144481666
-
The nucleotide receptor P2Y13 is a key regulator of hepatic high-density lipoprotein (HDL) endocytosis
-
S. Jacquet, C. Malaval, L.O. Martinez, K. Sak, C. Rolland, C. Perez, M. Nauze, E. Champagne, F. Terce, C. Gachet, B. Perret, X. Collet, J.M. Boeynaems, and R. Barbaras The nucleotide receptor P2Y13 is a key regulator of hepatic high-density lipoprotein (HDL) endocytosis Cell. Mol. Life Sci. 62 2005 2508 2515
-
(2005)
Cell. Mol. Life Sci.
, vol.62
, pp. 2508-2515
-
-
Jacquet, S.1
Malaval, C.2
Martinez, L.O.3
Sak, K.4
Rolland, C.5
Perez, C.6
Nauze, M.7
Champagne, E.8
Terce, F.9
Gachet, C.10
Perret, B.11
Collet, X.12
Boeynaems, J.M.13
Barbaras, R.14
-
7
-
-
56949098790
-
RhoA/ROCK i signalling downstream of the P2Y13 ADP-receptor controls HDL endocytosis in human hepatocytes
-
C. Malaval, M. Laffargue, R. Barbaras, C. Rolland, C. Peres, E. Champagne, B. Perret, F. Terce, X. Collet, and L.O. Martinez RhoA/ROCK I signalling downstream of the P2Y13 ADP-receptor controls HDL endocytosis in human hepatocytes Cell. Signal. 21 2009 120 127
-
(2009)
Cell. Signal.
, vol.21
, pp. 120-127
-
-
Malaval, C.1
Laffargue, M.2
Barbaras, R.3
Rolland, C.4
Peres, C.5
Champagne, E.6
Perret, B.7
Terce, F.8
Collet, X.9
Martinez, L.O.10
-
8
-
-
42249102617
-
P2 receptors, platelet function and pharmacological implications
-
C. Gachet P2 receptors, platelet function and pharmacological implications Thromb. Haemost. 99 2008 466 472
-
(2008)
Thromb. Haemost.
, vol.99
, pp. 466-472
-
-
Gachet, C.1
-
9
-
-
79960999130
-
Pharmacology and clinical trials of reversibly-binding P2Y12 inhibitors
-
R.F. Storey Pharmacology and clinical trials of reversibly-binding P2Y12 inhibitors Thromb. Haemost. 105 Suppl. 2011 S75 S81
-
(2011)
Thromb. Haemost.
, vol.105
, Issue.SUPPL.
-
-
Storey, R.F.1
-
10
-
-
77957962456
-
P2Y13 receptor is critical for reverse cholesterol transport
-
A.C. Fabre, C. Malaval, A. Ben Addi, C. Verdier, V. Pons, N. Serhan, L. Lichtenstein, G. Combes, T. Huby, F. Briand, X. Collet, N. Nijstad, U.J. Tietge, B. Robaye, B. Perret, J.M. Boeynaems, and L.O. Martinez P2Y13 receptor is critical for reverse cholesterol transport Hepatology 52 2010 1477 1483
-
(2010)
Hepatology
, vol.52
, pp. 1477-1483
-
-
Fabre, A.C.1
Malaval, C.2
Ben Addi, A.3
Verdier, C.4
Pons, V.5
Serhan, N.6
Lichtenstein, L.7
Combes, G.8
Huby, T.9
Briand, F.10
Collet, X.11
Nijstad, N.12
Tietge, U.J.13
Robaye, B.14
Perret, B.15
Boeynaems, J.M.16
Martinez, L.O.17
-
11
-
-
0141988913
-
Influence of the HDL receptor SR-BI on lipoprotein metabolism and atherosclerosis
-
B.L. Trigatti, M. Krieger, and A. Rigotti Influence of the HDL receptor SR-BI on lipoprotein metabolism and atherosclerosis Arterioscler. Thromb. Vasc. Biol. 23 2003 1732 1738
-
(2003)
Arterioscler. Thromb. Vasc. Biol.
, vol.23
, pp. 1732-1738
-
-
Trigatti, B.L.1
Krieger, M.2
Rigotti, A.3
-
13
-
-
33845261493
-
A rapid method of total lipid extraction and purification
-
E.G. Bligh, and W.J. Dyer A rapid method of total lipid extraction and purification Can. J. Biochem. Physiol. 37 1959 911 917
-
(1959)
Can. J. Biochem. Physiol.
, vol.37
, pp. 911-917
-
-
Bligh, E.G.1
Dyer, W.J.2
-
14
-
-
0030003283
-
Identification and quantitation of diacylglycerols in HDL and accessibility to lipase
-
C. Vieu, B. Jaspard, R. Barbaras, J. Manent, H. Chap, B. Perret, and X. Collet Identification and quantitation of diacylglycerols in HDL and accessibility to lipase J. Lipid Res. 37 1996 1153 1161
-
(1996)
J. Lipid Res.
, vol.37
, pp. 1153-1161
-
-
Vieu, C.1
Jaspard, B.2
Barbaras, R.3
Manent, J.4
Chap, H.5
Perret, B.6
Collet, X.7
-
15
-
-
0028231728
-
Specific binding of free apolipoprotein A-I to a high-affinity binding site on HepG2 cells: Characterization of two high-density lipoprotein sites
-
R. Barbaras, X. Collet, H. Chap, and B. Perret Specific binding of free apolipoprotein A-I to a high-affinity binding site on HepG2 cells: characterization of two high-density lipoprotein sites Biochemistry 33 1994 2335 2340
-
(1994)
Biochemistry
, vol.33
, pp. 2335-2340
-
-
Barbaras, R.1
Collet, X.2
Chap, H.3
Perret, B.4
-
16
-
-
84864835923
-
Lecithin:cholesterol acyltransferase: Old friend or foe in atherosclerosis?
-
S. Kunnen, and M. Van Eck Lecithin:cholesterol acyltransferase: old friend or foe in atherosclerosis? J. Lipid Res. 53 2012 1783 1799
-
(2012)
J. Lipid Res.
, vol.53
, pp. 1783-1799
-
-
Kunnen, S.1
Van Eck, M.2
-
17
-
-
0032484117
-
Liver-specific overexpression of scavenger receptor BI decreases levels of very low density lipoprotein ApoB, low density lipoprotein ApoB, and high density lipoprotein in transgenic mice
-
N. Wang, T. Arai, Y. Ji, F. Rinninger, and A.R. Tall Liver-specific overexpression of scavenger receptor BI decreases levels of very low density lipoprotein ApoB, low density lipoprotein ApoB, and high density lipoprotein in transgenic mice J. Biol. Chem. 273 1998 32920 32926
-
(1998)
J. Biol. Chem.
, vol.273
, pp. 32920-32926
-
-
Wang, N.1
Arai, T.2
Ji, Y.3
Rinninger, F.4
Tall, A.R.5
-
18
-
-
0033548442
-
Lower plasma levels and accelerated clearance of high density lipoprotein (HDL) and non-HDL cholesterol in scavenger receptor class B type i transgenic mice
-
Y. Ueda, L. Royer, E. Gong, J. Zhang, P.N. Cooper, O. Francone, and E.M. Rubin Lower plasma levels and accelerated clearance of high density lipoprotein (HDL) and non-HDL cholesterol in scavenger receptor class B type I transgenic mice J. Biol. Chem. 274 1999 7165 7171
-
(1999)
J. Biol. Chem.
, vol.274
, pp. 7165-7171
-
-
Ueda, Y.1
Royer, L.2
Gong, E.3
Zhang, J.4
Cooper, P.N.5
Francone, O.6
Rubin, E.M.7
-
19
-
-
0035816645
-
High density lipoprotein (hdl) particle uptake mediated by scavenger receptor class b type 1 results in selective sorting of hdl cholesterol from protein and polarized cholesterol secretion
-
D.L. Silver, N. Wang, X. Xiao, and A.R. Tall High density lipoprotein (hdl) particle uptake mediated by scavenger receptor class b type 1 results in selective sorting of hdl cholesterol from protein and polarized cholesterol secretion J. Biol. Chem. 276 2001 25287 25293
-
(2001)
J. Biol. Chem.
, vol.276
, pp. 25287-25293
-
-
Silver, D.L.1
Wang, N.2
Xiao, X.3
Tall, A.R.4
-
20
-
-
0037931116
-
Differential effects of scavenger receptor BI deficiency on lipid metabolism in cells of the arterial wall and in the liver
-
M. Van Eck, J. Twisk, M. Hoekstra, B.T. Van Rij, C.A. Van der Lans, I.S. Bos, J.K. Kruijt, F. Kuipers, and T.J. Van Berkel Differential effects of scavenger receptor BI deficiency on lipid metabolism in cells of the arterial wall and in the liver J. Biol. Chem. 278 2003 23699 23705
-
(2003)
J. Biol. Chem.
, vol.278
, pp. 23699-23705
-
-
Van Eck, M.1
Twisk, J.2
Hoekstra, M.3
Van Rij, B.T.4
Van Der Lans, C.A.5
Bos, I.S.6
Kruijt, J.K.7
Kuipers, F.8
Van Berkel, T.J.9
-
21
-
-
18144424371
-
Endocytosis is not required for the selective lipid uptake mediated by murine SR-BI
-
T.J. Nieland, M. Ehrlich, M. Krieger, and T. Kirchhausen Endocytosis is not required for the selective lipid uptake mediated by murine SR-BI Biochim. Biophys. Acta 1734 2005 44 51
-
(2005)
Biochim. Biophys. Acta
, vol.1734
, pp. 44-51
-
-
Nieland, T.J.1
Ehrlich, M.2
Krieger, M.3
Kirchhausen, T.4
-
22
-
-
33747092355
-
Quantitative analysis of SR-BI-dependent HDL retroendocytosis in hepatocytes and fibroblasts
-
B. Sun, E.R. Eckhardt, S. Shetty, D.R. van der Westhuyzen, and N.R. Webb Quantitative analysis of SR-BI-dependent HDL retroendocytosis in hepatocytes and fibroblasts J. Lipid Res. 47 2006 1700 1713
-
(2006)
J. Lipid Res.
, vol.47
, pp. 1700-1713
-
-
Sun, B.1
Eckhardt, E.R.2
Shetty, S.3
Van Der Westhuyzen, D.R.4
Webb, N.R.5
-
24
-
-
0030960169
-
Overexpression of the HDL receptor SR-BI alters plasma HDL and bile cholesterol levels
-
K.F. Kozarsky, M.H. Donahee, A. Rigotti, S.N. Iqbal, E.R. Edelman, and M. Krieger Overexpression of the HDL receptor SR-BI alters plasma HDL and bile cholesterol levels Nature 387 1997 414 417
-
(1997)
Nature
, vol.387
, pp. 414-417
-
-
Kozarsky, K.F.1
Donahee, M.H.2
Rigotti, A.3
Iqbal, S.N.4
Edelman, E.R.5
Krieger, M.6
-
25
-
-
70350048558
-
Scavenger receptor class B type i mediates biliary cholesterol secretion independent of ATP-binding cassette transporter g5/g8 in mice
-
H. Wiersma, A. Gatti, N. Nijstad, R.P. Oude Elferink, F. Kuipers, and U.J. Tietge Scavenger receptor class B type I mediates biliary cholesterol secretion independent of ATP-binding cassette transporter g5/g8 in mice Hepatology 50 2009 1263 1272
-
(2009)
Hepatology
, vol.50
, pp. 1263-1272
-
-
Wiersma, H.1
Gatti, A.2
Nijstad, N.3
Oude Elferink, R.P.4
Kuipers, F.5
Tietge, U.J.6
-
27
-
-
79955771069
-
Cholesteryl ester transfer protein expression partially attenuates the adverse effects of SR-BI receptor deficiency on cholesterol metabolism and atherosclerosis
-
M. El Bouhassani, S. Gilibert, M. Moreau, F. Saint-Charles, M. Treguier, F. Poti, M.J. Chapman, W. Le Goff, P. Lesnik, T. Huby, and M. Tréguier Cholesteryl ester transfer protein expression partially attenuates the adverse effects of SR-BI receptor deficiency on cholesterol metabolism and atherosclerosis J. Biol. Chem. 286 2011 17227 17238
-
(2011)
J. Biol. Chem.
, vol.286
, pp. 17227-17238
-
-
El Bouhassani, M.1
Gilibert, S.2
Moreau, M.3
Saint-Charles, F.4
Treguier, M.5
Poti, F.6
Chapman, M.J.7
Le Goff, W.8
Lesnik, P.9
Huby, T.10
Tréguier, M.11
-
28
-
-
38849140840
-
Is raising HDL a futile strategy for atheroprotection?
-
T. Joy, and R.A. Hegele Is raising HDL a futile strategy for atheroprotection? Nat. Rev. Drug Discov. 7 2008 143 155
-
(2008)
Nat. Rev. Drug Discov.
, vol.7
, pp. 143-155
-
-
Joy, T.1
Hegele, R.A.2
-
29
-
-
84055207675
-
Anacetrapib, a novel CETP inhibitor: Pursuing a new approach to cardiovascular risk reduction
-
D.E. Gutstein, R. Krishna, D. Johns, H.K. Surks, H.M. Dansky, S. Shah, Y.B. Mitchel, J. Arena, and J.A. Wagner Anacetrapib, a novel CETP inhibitor: pursuing a new approach to cardiovascular risk reduction Clin. Pharmacol. Ther. 91 2012 109 122
-
(2012)
Clin. Pharmacol. Ther.
, vol.91
, pp. 109-122
-
-
Gutstein, D.E.1
Krishna, R.2
Johns, D.3
Surks, H.K.4
Dansky, H.M.5
Shah, S.6
Mitchel, Y.B.7
Arena, J.8
Wagner, J.A.9
-
31
-
-
84864856351
-
An update on the clinical development of dalcetrapib (RO4607381), a cholesteryl ester transfer protein modulator that increases HDL cholesterol levels
-
D. Rhainds, B.J. Arsenault, M.R. Brodeur, and J.-C. Tardif An update on the clinical development of dalcetrapib (RO4607381), a cholesteryl ester transfer protein modulator that increases HDL cholesterol levels Future Cardiol. 8 2012 513 531
-
(2012)
Future Cardiol.
, vol.8
, pp. 513-531
-
-
Rhainds, D.1
Arsenault, B.J.2
Brodeur, M.R.3
Tardif, J.-C.4
-
32
-
-
50249169416
-
HDL: Still a target for new therapies?
-
S.J. Nicholls HDL: still a target for new therapies? Curr. Opin. Investig. Drugs 9 2008 950 956
-
(2008)
Curr. Opin. Investig. Drugs
, vol.9
, pp. 950-956
-
-
Nicholls, S.J.1
-
33
-
-
77957940930
-
The complexity of HDL
-
G.A. Francis The complexity of HDL Biochim. Biophys. Acta 1801 2010 1286 1293
-
(2010)
Biochim. Biophys. Acta
, vol.1801
, pp. 1286-1293
-
-
Francis, G.A.1
|